[시장보고서]세계의 방출 제어형 약물전달 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 기술별, 방출 메커니즘별, 용도별, 지역별, 경쟁별(2020-2030년)

세계의 방출 제어형 약물전달 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 기술별, 방출 메커니즘별, 용도별, 지역별, 경쟁별(2020-2030년)

Controlled Release Drug Delivery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Release Mechanism, By Application, By Region and Competition, 2020-2030F

상품코드 : 1697980

리서치사 : TechSci Research

발행일 : 2025년 03월

페이지 정보 : 영문 186 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,195,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,571,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,013,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

방출 제어형 약물전달 전달 세계 시장 규모는 2024년 562억 4,000만 달러로 평가되었습니다. 예측 기간 동안 1,037억 5,000만 달러에 달했고, 2030년까지 10.72%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.

제약회사들이 약물의 효과와 환자의 순응도를 높이는 데 점점 더 집중하면서 방출 제어형 약물전달 전달 시장이 확대되고 있습니다. 서방형 약물전달시스템은 장기간에 걸쳐 약물을 점진적으로 방출하여 투여 횟수를 줄이고 부작용을 최소화할 수 있습니다. 이 시장은 정밀의료와 치료 성적을 향상시키는 지속형 제제에 대한 수요가 증가하면서 강력한 성장세를 보이고 있습니다. 주요 기업들은 약물 방출 메커니즘을 최적화하기 위해 첨단 고분자 기술, 나노기술 기반 전달 시스템, 생분해성 임플란트에 투자하고 있습니다. 심혈관 질환, 당뇨병, 신경 질환과 같은 만성 질환의 유병률 증가는 치료 순응도를 개선하는 제어 방출 제제의 보급을 더욱 촉진하고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	562억 4,000만 달러
시장 규모 : 2030년	1,037억 5,000만 달러
CAGR : 2025-2030년	10.72%
급성장 부문	타겟 배송
최대 시장	북미

이 시장은 약물 제형화 및 전달 시스템의 기술적 진보로 인해 보다 효율적이고 표적화된 치료가 가능해졌습니다. 마이크로스피어, 리포솜, 경피 패치와 같은 기술 혁신으로 약물의 생체 이용률과 안정성이 향상되고 있습니다. 제약사들은 특히 복잡한 생물학적 제제 및 유전자 치료제의 방출 제어 제제 개발을 가속화하기 위해 전략적 제휴를 적극적으로 모색하고 있습니다. 의료비 지출 증가와 새로운 약물 전달법에 대한 규제 당국의 우호적인 지원이 시장 확대를 촉진하고 있습니다. 환자 중심 솔루션에 대한 수요가 업계 트렌드를 형성하고 있으며, 경구제, 주사제, 이식형 약물 전달 시스템이 널리 받아들여지고 있습니다. 바이오 의약품과 개인 맞춤형 의료의 급격한 증가는 유리한 기회를 제공하고, 첨단 약물 캡슐화 기술의 추가 연구 및 개발을 촉진하고 있습니다.

주요 시장 성장 촉진요인

만성질환 증가

주요 시장 이슈

규제 장벽과 승인 지연

주요 시장 동향

생분해성 및 이식형 약물 전달 시스템

시장 규모와 예측
- 금액별
시장 점유율과 예측
- 기술별(Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal,Targeted Delivery, 기타)
- 방출 메커니즘별(폴리머 기반 시스템, 마이크로 리저버 파티션 제어 약물전달 시스템, 피드백 제어 약물전달 시스템, 활성화 변조 약물전달 시스템, 화학적 활성화)
- 용도별(정량 흡입기, 주사제, 경피 및 안구 패치, 주입 펌프, 경구 제어 약물전달 시스템, 약물 용출 스텐트)
- 지역별
- 기업별(2024년)
시장 맵

제6장 북미의 방출 제어형 약물전달 시장 전망

시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 방출 제어형 약물전달 시장 전망

시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 독일
- 영국
- 이탈리아
- 프랑스
- 스페인

제8장 아시아태평양의 방출 제어형 약물전달 시장 전망

시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 남미의 방출 제어형 약물전달 시장 전망

시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 방출 제어형 약물전달 시장 전망

시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트

제11장 시장 역학

성장 촉진요인과 과제

제12장 시장 동향과 발전

최근 동향
제품 출시
인수합병(M&A)

제13장 세계의 방출 제어형 약물전달 시장 : SWOT 분석

제14장 경쟁 구도

Orbis Biosciences, Inc.
Merck and Co., Inc.
Alkermes plc
Johnson and Johnson
Coating Place, Inc.
Corium International, Inc.
Depomed, Inc.
Pfizer, Inc
Aradigm Corporation
Capsugel Inc

제15장 전략적 제안

제16장 리서치사에 대해 & 면책사항

LSH

영문 목차

영문목차

Global Controlled Release Drug Delivery Market was valued at USD 56.24 Billion in 2024 and is expected to reach USD 103.75 Billion in the forecast period with a CAGR of 10.72% through 2030. The controlled release drug delivery market is expanding as pharmaceutical companies increasingly focus on enhancing drug efficacy and patient compliance. This system enables the gradual release of drugs over an extended period, reducing dosing frequency and minimizing side effects. The market is witnessing strong growth due to rising demand for precision medicine and sustained drug formulations that improve therapeutic outcomes. Key players are investing in advanced polymer technologies, nanotechnology-based delivery systems, and biodegradable implants to optimize drug release mechanisms. The increasing prevalence of chronic diseases such as cardiovascular disorders, diabetes, and neurological conditions is further driving adoption, as controlled release formulations offer improved treatment adherence.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 56.24 Billion
Market Size 2030	USD 103.75 Billion
CAGR 2025-2030	10.72%
Fastest Growing Segment	Targeted Delivery
Largest Market	North America

The market benefits from technological advancements in drug formulation and delivery systems, enabling more efficient and targeted therapies. Innovations in microspheres, liposomes, and transdermal patches are enhancing drug bioavailability and stability. Pharmaceutical companies are actively seeking strategic collaborations to accelerate the development of controlled release formulations, particularly for complex biologics and gene therapies. Rising healthcare expenditure and favorable regulatory support for novel drug delivery methods are fostering market expansion. Demand for patient-centric solutions is shaping industry trends, with oral, injectable, and implantable drug delivery systems gaining widespread acceptance. The surge in biopharmaceuticals and personalized medicine presents lucrative opportunities, encouraging further research and development in advanced drug encapsulation techniques.

Key Market Drivers

Increasing Prevalence of Chronic Diseases

The global incidence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and respiratory disorders continues to rise. According to the World Health Organization (WHO), cardiovascular diseases accounted for approximately 19 million deaths in 2021, cancers for 10 million, chronic respiratory diseases for 4 million, and diabetes for over 2 million, including deaths from kidney disease caused by diabetes. This increase is largely attributed to factors such as sedentary lifestyles, poor dietary habits, and an aging population. Notably, the number of people living with diabetes surged from 200 million in 1990 to 830 million in 2022, with prevalence rising more rapidly in low- and middle-income countries.

Managing chronic diseases often necessitates long-term medication regimens, which can be challenging for patients to adhere to consistently. Studies have shown that approximately 50% of patients with chronic conditions demonstrate poor medication adherence, leading to suboptimal health outcomes and increased healthcare costs.

Key Market Challenges

Regulatory Hurdles and Approval Delays

Stringent Regulatory Requirements: Developing and gaining regulatory approval for controlled release drug delivery systems involves navigating complex and stringent regulatory pathways. Regulatory agencies, such as the FDA (U.S. Food and Drug Administration) and the EMA (European Medicines Agency), have rigorous requirements to ensure the safety and efficacy of these systems.

The regulatory approval process can be lengthy and resource-intensive, significantly delaying the market entry of new controlled release products. This can discourage investment and slow down market growth. Regulatory requirements and guidelines for drug delivery systems may evolve over time, necessitating costly adjustments to meet updated standards.

Key Market Trends

Biodegradable and Implantable Drug Delivery Systems

Growing environmental awareness and sustainability concerns have prompted the development of biodegradable drug delivery systems. These systems are designed to gradually release drugs while breaking down harmlessly in the body, reducing waste and environmental impact.

Implantable controlled release systems, such as biodegradable implants, are gaining prominence for delivering long-lasting therapeutics. They offer convenience for patients by eliminating the need for frequent dosing and provide sustained drug release over extended periods. Biodegradable and implantable systems are particularly valuable in treating chronic conditions, as they can provide continuous drug delivery, potentially improving patient compliance and therapeutic outcomes.

Key Market Players

Orbis Biosciences, Inc.
Merck and Co., Inc.
Alkermes plc
Johnson and Johnson
Coating Place, Inc.
Corium International, Inc.
Depomed, Inc.
Pfizer, Inc
Aradigm Corporation
Capsugel Inc

Report Scope:

In this report, the Global Controlled Release Drug Delivery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Controlled Release Drug Delivery Market, By Technology:

Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others

Controlled Release Drug Delivery Market, By Release Mechanism:

Polymer Based Systems
Micro Reservoir Partition Controlled Drug Delivery Systems
Feedback Regulated Drug Delivery Systems
Activation-modulated Drug Delivery Systems
Chemically Activated

Controlled Release Drug Delivery Market, By Application:

Metered Dose Inhalers
Injectable
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-drug delivery Systems
Drug Eluting Stents

Controlled Release Drug Delivery Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Controlled Release Drug Delivery Market.

Available Customizations:

Global Controlled Release Drug Delivery market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Applications
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Controlled Release Drug Delivery Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Technology (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Others)
- 5.2.2. By Release Mechanism (Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-modulated Drug Delivery Systems, Chemically Activated)
- 5.2.3. By Application (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-drug delivery Systems, Drug Eluting Stents)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Controlled Release Drug Delivery Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Technology
- 6.2.2. By Release Mechanism
- 6.2.3. By Application
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Controlled Release Drug Delivery Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Technology
    - 6.3.1.2.2. By Release Mechanism
    - 6.3.1.2.3. By Application
- 6.3.2. Canada Controlled Release Drug Delivery Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Technology
    - 6.3.2.2.2. By Release Mechanism
    - 6.3.2.2.3. By Application
- 6.3.3. Mexico Controlled Release Drug Delivery Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Technology
    - 6.3.3.2.2. By Release Mechanism
    - 6.3.3.2.3. By Application

7. Europe Controlled Release Drug Delivery Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Technology
- 7.2.2. By Release Mechanism
- 7.2.3. By Application
7.3. Europe: Country Analysis
- 7.3.1. Germany Controlled Release Drug Delivery Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Technology
    - 7.3.1.2.2. By Release Mechanism
    - 7.3.1.2.3. By Application
- 7.3.2. United Kingdom Controlled Release Drug Delivery Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Technology
    - 7.3.2.2.2. By Release Mechanism
    - 7.3.2.2.3. By Application
- 7.3.3. Italy Controlled Release Drug Delivery Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Technology
    - 7.3.3.2.2. By Release Mechanism
    - 7.3.3.2.3. By Application
- 7.3.4. France Controlled Release Drug Delivery Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Technology
    - 7.3.4.2.2. By Release Mechanism
    - 7.3.4.2.3. By Application
- 7.3.5. Spain Controlled Release Drug Delivery Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Technology
    - 7.3.5.2.2. By Release Mechanism
    - 7.3.5.2.3. By Application

8. Asia-Pacific Controlled Release Drug Delivery Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Technology
- 8.2.2. By Release Mechanism
- 8.2.3. By Application
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Controlled Release Drug Delivery Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Technology
    - 8.3.1.2.2. By Release Mechanism
    - 8.3.1.2.3. By Application
- 8.3.2. India Controlled Release Drug Delivery Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Technology
    - 8.3.2.2.2. By Release Mechanism
    - 8.3.2.2.3. By Application
- 8.3.3. Japan Controlled Release Drug Delivery Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Technology
    - 8.3.3.2.2. By Release Mechanism
    - 8.3.3.2.3. By Application
- 8.3.4. South Korea Controlled Release Drug Delivery Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Technology
    - 8.3.4.2.2. By Release Mechanism
    - 8.3.4.2.3. By Application
- 8.3.5. Australia Controlled Release Drug Delivery Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Technology
    - 8.3.5.2.2. By Release Mechanism
    - 8.3.5.2.3. By Application

9. South America Controlled Release Drug Delivery Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Technology
- 9.2.2. By Release Mechanism
- 9.2.3. By Application
9.3. South America: Country Analysis
- 9.3.1. Brazil Controlled Release Drug Delivery Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Technology
    - 9.3.1.2.2. By Release Mechanism
    - 9.3.1.2.3. By Application
- 9.3.2. Argentina Controlled Release Drug Delivery Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Technology
    - 9.3.2.2.2. By Release Mechanism
    - 9.3.2.2.3. By Application
- 9.3.3. Colombia Controlled Release Drug Delivery Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Technology
    - 9.3.3.2.2. By Release Mechanism
    - 9.3.3.2.3. By Application

10. Middle East and Africa Controlled Release Drug Delivery Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Technology
- 10.2.2. By Release Mechanism
- 10.2.3. By Application
10.3. MEA: Country Analysis
- 10.3.1. South Africa Controlled Release Drug Delivery Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Technology
    - 10.3.1.2.2. By Release Mechanism
    - 10.3.1.2.3. By Application
- 10.3.2. Saudi Arabia Controlled Release Drug Delivery Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Technology
    - 10.3.2.2.2. By Release Mechanism
    - 10.3.2.2.3. By Application
- 10.3.3. UAE Controlled Release Drug Delivery Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Technology
    - 10.3.3.2.2. By Release Mechanism
    - 10.3.3.2.3. By Application

11. Market Dynamics

11.1. Drivers & Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Controlled Release Drug Delivery Market: SWOT Analysis

14. Competitive Landscape

14.1. Orbis Biosciences, Inc.
14.2. Merck and Co., Inc.
14.3. Alkermes plc
14.4. Johnson and Johnson
14.5. Coating Place, Inc.
14.6. Corium International, Inc.
14.7. Depomed, Inc.
14.8. Pfizer, Inc
14.9. Aradigm Corporation
14.10.Capsugel Inc